Kellett Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$638K Buy
2,513
+107
+4% +$24.9K 0.3% 41
2026
Q1
$588K Buy
2,406
+296
+14% +$68.9K 0.32% 42
2025
Q4
$437K Buy
2,110
+38
+2% +$7.51K 0.25% 47
2025
Q3
$384K Buy
2,072
+22
+1% +$3.77K 0.23% 48
2025
Q2
$313K Buy
2,050
+274
+15% +$42.1K 0.2% 50
2025
Q1
$295K Buy
1,776
+127
+8% +$19.9K 0.2% 54
2024
Q4
$238K Sell
1,649
-320
-16% -$49.6K 0.16% 59
2024
Q3
$319K Buy
1,969
+323
+20% +$51.5K 0.23% 52
2024
Q2
$241K Sell
1,646
-235
-12% -$35K 0.19% 59
2024
Q1
$298K Sell
1,881
-2
-0.1% -$318 0.21% 65
2023
Q4
$295K Buy
1,883
+3
+0.2% +$460 0.22% 59
2023
Q3
$293K Buy
1,880
+68
+4% +$11.2K 0.25% 45
2023
Q2
$300K Sell
1,812
-351
-16% -$56.7K 0.27% 39
2023
Q1
$335K Buy
2,163
+3
+0.1% +$484 0.32% 34
2022
Q4
$382K Buy
2,160
+2
+0.1% +$345 0.37% 32
2022
Q3
$375K Sell
2,158
-98
-4% -$16.6K 0.46% 27
2022
Q2
$400K Buy
2,256
+3
+0.1% +$535 0.52% 27
2022
Q1
$399K Buy
2,253
+302
+15% +$51.4K 0.32% 33
2021
Q4
$334K Buy
+1,951
New +$319K 0.26% 41

Other funds holding JNJ

Kellett Wealth Advisors's JNJ Position: Q2 2026 in Review

Kellett Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 4.4% in Q2 2026, buying an estimated $24.9K and bringing the position to 2,513 shares worth $638K. The position accounts for 0.3% of the portfolio, ranked #41.

Kellett Wealth Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 1,809 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Kellett Wealth Advisors held 2,513 shares of Johnson & Johnson worth $638K as of Q2 2026.
  • Kellett Wealth Advisors bought 107 Johnson & Johnson shares in Q2 2026, an estimated $24.9K.
  • Johnson & Johnson made up 0.3% of Kellett Wealth Advisors's portfolio in Q2 2026, its #41 holding.
  • Kellett Wealth Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 1,809 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Kellett Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.